Compounds > cuprizone

Page last updated: 2024-08-21

cuprizone and sphingosine

cuprizone has been researched along with sphingosine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antel, JP; Dukala, D; Kim, HJ; Ludwin, SK; Miron, VE; Proia, RL; Soliven, B; Traka, M	1
Apicco, D; Guckian, K; Hu, Y; Ji, B; Lee, X; Mi, S; Miller, RH; Pepinsky, RB	1
Ahmad, I; Deshmukh, VA; Gage, FH; Green, CC; Kerman, B; Kim, HJ; Kondo, T; Lairson, LL; Lawson, BR; Lyssiotis, CA; Padmanabhan, K; Schultz, PG; Swoboda, JG; Tardif, V; Theofilopoulos, AN	1
Amor, S; Beyer, C; Clarner, T; Kipp, M; Schmidt, T; Slowik, A	1
Alme, MN; Bø, L; Myhr, KM; Nystad, AE; Torkildsen, Ø; Vedeler, CA; Wergeland, S	1

Other Studies

5 other study(ies) available for cuprizone and sphingosine

Article	Year
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:5 Topics: Animals; Axons; Blotting, Western; Corpus Callosum; Cuprizone; Demyelinating Diseases; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Myelin Sheath; Oligodendroglia; Propylene Glycols; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine	2011
Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo. Molecular and cellular neurosciences, 2011, Volume: 48, Issue:1 Topics: Animals; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Regeneration; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine	2011
A regenerative approach to the treatment of multiple sclerosis. Nature, 2013, Oct-17, Volume: 502, Issue:7471 Topics: Animals; Antiparkinson Agents; Benztropine; Cell Differentiation; Coculture Techniques; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Immune System; Mice; Mice, Inbred C57BL; Models, Biological; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Propylene Glycols; Rats; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Recurrence; Regeneration; Sphingosine; Stem Cells	2013
The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination. British journal of pharmacology, 2015, Volume: 172, Issue:1 Topics: Amyloid beta-Protein Precursor; Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Fingolimod Hydrochloride; Gene Expression Regulation; Liver; Male; Membrane Proteins; Mice, Inbred C57BL; Neuroprotective Agents; Phosphatidate Phosphatase; Phosphoric Monoester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine	2015
Fingolimod does not enhance cerebellar remyelination in the cuprizone model. Journal of neuroimmunology, 2015, Aug-15, Volume: 285 Topics: Animals; Cerebellum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Propylene Glycols; Sphingosine	2015